Leukemia Clinical Trials

Showing 501-520 of 8,366 trials

A Phase 3 Study of IN10018 in Combination With D-1553 Versus Standard Therapy for First Line Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation

NCT07174908

This is a multicenter, randomized, open-label, phase III clinical study, to evaluate the efficacy and safety of IN10018 in combination with D-1553 as compared to anti-PD-1 monoclonal antibody (mAb) in combination with platinum and pemetrexed as the first-line treatment for the locally advanced or metastatic KRASG12C mutation-positive non-squamous non-small cell lung cancer (NSCLC).

Non-Small Cell Lung Cancer

InxMed (Shanghai) Co., Ltd.400 participantsStarted Sep 2025

Beijing, Beijing Municipality, China • Guangzhou, Guangdong, China • Zhengzhou, Henan, China +8 more locations

RECRUITINGNA

Engagement of Veterans With Lung Cancer

NCT07219251

This research study will help our understanding of whether additional support for Veterans with lung cancer can improve their quality of life.

Lung Cancer (NSCLC)Lung AdenocarcinomaLung Cancer, Non-Small Cell+3 more

Palo Alto Veterans Institute for Research194 participantsStarted Feb 2026

Palo Alto, California, United States

A Phase 3 Study of IN10018 in Combination With D-1553 Versus Standard Therapy for First Line Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation

Engagement of Veterans With Lung Cancer

Related Searches

FHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid Leukemia

Lattice Radiation Therapy Versus Conventional Radiation Therapy for the Palliation of Large Tumors

Safety and Effectiveness of the Crystalline Sirolimus-Eluting Device in Patients With Coronary Artery Disease

Chemogenomic Profiling in Hematological Malignancies (HEM-Profiling 2021)

Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors

Supportive Care for Cognitively Impaired Patients and Families

VAG Versus Standard Chemotherapy With FLT3 Inhibitor in Adult Patients With FLT3-Mutated AML

MRI-Based Lesion Differentiation in Older Patients With Multiple Sclerosis

A Study of LY4175408 in Participants With Advanced Cancer

Oral Azacitidine in Transplant-Eligible Patients With Acute Myeloid Leukemia (AML) Suffering From Health-Inequality

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors

Phase I Nab-Paclitaxel Plus Gemcitabine With Proton Therapy for Locally Advanced Pancreatic Cancer (LAPC)

AML/MDS Drug Sensitization by in Vivo Chemotherapy Administration

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer

Necrosectomy With Cryotechnology for Accelerated Removal